Reply to: "Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis".
Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Tracey G
TG
Simon
Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Lindsay Y
LY
King
Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: rtchung@partners.org.
Raymond T
RT
Chung
D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology*; D008103:Liver Cirrhosis / Q000517:prevention & control*; D008297:Male
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors